Andrada, Necel .

HRN: 27-96-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2025
CEFUROXIME 500MG (TAB)
10/20/2025
10/27/2025
ORAL
500 Mg
BID
S/p Nsvd With Rmle; Thinly Msaf
Waiting Final Action 
10/25/2025
CEFUROXIME 1.5GM (VIAL)
10/25/2025
10/26/2025
IV
1.5g
Q8hours
R/o Endometritis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: